Keyphrases
Disorders of Consciousness
87%
Quantitative Pupillometry
56%
Out-of-hospital Cardiac Arrest
44%
Coma
42%
Acute Disease
41%
Intensive Care Unit
40%
Cardiac Arrest
38%
Functional Magnetic Resonance Imaging
33%
Acute Brain Injury
31%
Intensive Care Unit Patients
30%
Neuroprognostication
30%
Comatose Patients
29%
Brain Death
28%
Multimodal Prediction
28%
Blood Oxygenation
28%
Oxygenation Targets
28%
Blood Pressure Target
28%
Confidence Interval
27%
Automated Pupillometry
27%
Brain Injury
25%
Death by Neurologic Criteria
21%
Digital Subtraction Angiography
21%
Recovery of Consciousness
21%
Pupillary Light Reflex
20%
Unfavorable Outcome
19%
Pupillometry
18%
Pupillary Response
16%
Pupillary
16%
Pupillary Dilation
16%
Electroencephalography
16%
Denmark
16%
Curing Coma Campaign
15%
Cardiac Arrest Survivor
14%
Comatose Survivors
14%
In-hospital Cardiac Arrest
14%
Methylphenidate
14%
Brimonidine
14%
Takotsubo Cardiomyopathy
14%
Precision Medicine
14%
Eye Drops
14%
Apomorphine
14%
12-month Outcomes
14%
Response Variable
14%
Manual Evaluation
14%
Cardiac Patients
14%
3-month Outcome
14%
Signatures of Consciousness
14%
Covert Consciousness
14%
Organ Transplant
14%
Randomized Crossover Study
14%
Medicine and Dentistry
Disorders of Consciousness
100%
Pupillometry
79%
Intensive Care Unit
67%
Brain Injury
57%
Coma
54%
Acute Disease
54%
Heart Arrest
43%
Out of Hospital Cardiac Arrest
41%
Functional Magnetic Resonance Imaging
32%
Blood Pressure
32%
Pupillary Reflex
30%
Blood Oxygenation
28%
Consciousness Level
17%
Pupillary Response
16%
Prognostication
14%
Reproducibility
14%
Digital Subtraction Angiography
14%
Apomorphine
14%
Endotype
14%
Arterial Spin Labeling
14%
Personalized Medicine
14%
Prevalence
14%
Transplantation
14%
Placebo
14%
Magnetic Resonance Imaging
14%
Methylphenidate
14%
Brain Death
14%
Brain Blood Flow
14%
Brimonidine
14%
Wakefulness
13%
Hazard Ratio
12%
Minimally Conscious State
11%
Awareness
11%
Cognition
9%
Diagnosis
8%
Volunteer
8%
Patient Referral
7%
False Positive Result
6%
Spin Echo
6%
Mean Corpuscular Volume
5%
Ligation
5%
Neurovascular Coupling
5%
Analeptic
5%
Study Participant
5%
Life Sustaining Treatment
5%
Anisocoria
5%
Clinical Trial
5%